Capstone Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Capstone Asset Management's GILD Position: Q2 2017 in Review
Capstone Asset Management increased its Gilead Sciences (GILD) stake by 4% in Q2 2017, buying an estimated $575K and bringing the position to 223,599 shares worth $15.8M. The position accounts for 0.44% of the portfolio, ranked #43.
Capstone Asset Management first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.
- Capstone Asset Management held 223,599 shares of Gilead Sciences worth $15.8M as of Q2 2017.
- Capstone Asset Management bought 8,643 Gilead Sciences shares in Q2 2017, an estimated $575K.
- Gilead Sciences made up 0.44% of Capstone Asset Management's portfolio in Q2 2017, its #43 holding.
- Capstone Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
- 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.